METHODS OF TREATING FGF21-ASSOCIATED DISORDERS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160051628A1
SERIAL NO

14676863

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the identification of new polypeptide and protein variants of fibroblast growth factor 21 (FGF21) that have improved pharmaceutical properties. Also disclosed are methods for treating FGF21-associated disorders, including metabolic conditions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC250 MASSACHUSETTS AVENUE CAMBRIDGE MA 02139

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BOETTCHER, Brian R Winchester, US 11 291
CAPLAN, Shari L Lunenburg, US 6 270
DANIELS, Douglas S Arlington, US 10 190
GEIERSTANGER, Bernhard H Solana Beach, US 6 305
HAMAMATSU, Norio Belmont, US 16 206
LICHT, Stuart Cambridge, US 80 589
LOEW, Andreas Somerville, US 114 2037
WELDON, Stephen Craig Leominster, US 11 190

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation